Navigation Links
Code Hennessy & Simmons LLC Announces Sale of Suture Express, Inc.

CHICAGO, Jan. 28 /PRNewswire/ -- Code Hennessy & Simmons LLC ("CHS") announced the sale of Suture Express, Inc., a portfolio investment of CHS Private Equity V LP and Linden LLC, to Diamond Castle Partners, a New York-based private equity firm.  

Suture Express is a distributor of sutures, endo-mechanical products and other disposable medical and surgical products.  Suture Express offers over 1,600 acute care hospitals and surgery centers a comprehensive assortment of over 6,000 SKUs with no minimum order size, no required order frequency and guaranteed next-day delivery for most orders.  For additional information, visit

CHS led the investment in Suture Express in August 2006 and partnered with Linden in a buyout from the company's founders.  CHS and Linden successfully transitioned the leadership of the business and have worked closely with management to significantly grow revenue and market share as well as expand the company's customer base and product offering.

Ed Kuklenski, President and CEO of Suture Express, said, "CHS and Linden were instrumental in helping us build a world-class board of directors and achieve numerous growth initiatives.  Their combined healthcare expertise was invaluable as we grew our business substantially over the past several years.  We now look forward to working with Diamond Castle Partners to continue to build upon our past success."

Tom Formolo, Partner at CHS, said, "It was a pleasure to work with Ed Kuklenski and the management team at Suture Express.  With the company's history of growth, unique business model and best-in-class customer service levels, we are confident Suture Express will continue its track record of success and remarkable customer loyalty."   Ed Lhee, Partner at CHS, stated, "Suture Express fit well with our healthcare services strategy to pursue businesses that help improve the quality and efficiency of healthcare while providing value-added services for customers."  

CHS is a Chicago-based private equity firm specializing in private equity investments and recapitalizations of middle market companies in partnership with management. CHS targets well-managed companies focused on growth with enterprise values between $75 million and $1.0 billion. With particular expertise in the Business & Consumer Services, Consumer, Distribution, and Infrastructure & Industrial Products sectors, CHS has completed 73 platform investments and 211 add-on investments. Founded in 1988, CHS has formed five private equity funds and currently manages over $2.8 billion of capital. For additional information about CHS, visit

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries.  Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations.  Linden's portfolio includes BarrierSafe Solutions International, Behavioral Centers of America, Corpak MedSystems, Drayer Physical Therapy Institute, Focused Health Solutions and Ranir.  For additional information about Linden, please refer to the firm's website at

William Blair & Company, L.L.C. provided financial advisory services to Suture Express on the transaction and Kirkland & Ellis LLP provided legal advice.  

SOURCE Code Hennessy & Simmons LLC



SOURCE Code Hennessy & Simmons LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: